By M T
Behind the Batch spotlights the moments that shape the people pioneering cell and gene therapy. Failed batches, first viable runs, tech transfers, and everything in between. In episode 1, our host Alex Shephard chats with Andre Raposo, Senior Director of Innovation about his journey from fundamental HIV research to leading innovation in viral vector manufacturing … Continued
By M T
BEDFORD, UK, 16th February 2026 / Tozaro Limited, a company leveraging molecular modelling and ML to design and develop stable, cost-effective, specific and selective polymer-based ligands, announces a £6m/$8.2m funding round. The investment was led by Mercia Ventures, which was investing from the Midlands Engine Investment Fund II and from its own funds, alongside other … Continued
By M T
Bedfordshire, UK, 17 September 2025: Tozaro, an emerging technology provider in the field of cell and gene therapy manufacturing, is pleased to announce today that it has been awarded £154,000 in funding as part of a consortium developing novel tools to improve lentiviral vector manufacturing. The consortium includes Virica (supported through the National Research Council … Continued